The acellular dermal matrix is widely used in reconstructive procedures such as breast reconstruction, hernia repair, abdominal wall reconstruction, and facial reconstructive treatments. It mimics the qualities of human skin and prevents extra fluid build-up or infection at surgical sites. The rising incidence of injuries, burns, and cancers has increased the demand for reconstructive surgeries, thereby driving the demand for acellular dermal matrices. Additionally, acellular dermal matrices reduce donor site morbidity and provide mechanical support to soft tissues and organs after tissue expander-based breast reconstruction.
The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Rising demand for facial reconstructive treatments: Facial reconstructive treatments are gaining popularity as they help restore normalcy and self-confidence in patients suffering from conditions like facial cancer, trauma, and burns. Acellular dermal matrices play a vital role in such reconstructive procedures.
Focus on research and development: Key players are investing heavily in R&D to develop new biomaterials mimicking native skin properties closer. Ongoing innovations are expected to widen the application scope of acellular dermal matrices over the forecast period.
The growing prevalence of injuries, cancers, and trauma cases is contributing to the increasing demand for reconstructive surgeries. This rising demand for reconstructive procedures acts as a key driver for the U.S. acellular dermal matrices market. Innovation in biomaterials is further augmenting market growth
The U.S. acellular dermal matrices market is dominated by the allograft sub segment. This sub segment held around 70% market share in 2023 owing to the various advantages it offers such as biocompatibility, less risk of rejection, and ability heal wounds efficiently. The xenograft sub segment is also growing at a steady pace due to rising number of burns cases in the country.
Political: The market is positively impacted by the policies supporting wound care management in the country. The government aims to reduce healthcare costs associated with chronic and complicated wounds through reimbursement policies.
Economic: Rising healthcare expenditure and disposable incomes have boosted the demand for advanced wound care products. However, pricing pressures may impact industry players.
Social: Growing elderly population prone to diseases and injuries is driving market growth. Moreover, increasing awareness about available treatment options is encouraging the adoption of acellular dermal matrices.
Technological: Companies are investing in R&D to develop advanced biomaterials and matrices with improved healing properties. 3D printing technology is also being explored to develop customized skin substitutes.
The Global U.S. Acellular Dermal Matrices Market Growth is expected to witness high. Regional analysis comprises- The Western region dominates the market and is expected to continue its dominance fueled by growing burn and diabetic foot ulcer cases. States like California and Texas have emerged as major revenue generators. The global U.S. Acellular Dermal Matrices Market is estimated to be valued at US$ 2783.32 Mn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030.
Key players related content comprises- Key players operating in the U.S. acellular dermal matrices market are Biomet, Inc., Wright Medical Technology, Inc., Smith & Nephew Plc, and Stryker. Biomet dominates the market owing to its wide product portfolio and robust distribution network across the country. The company aims to strengthen its market position through investments in advanced wound care technologies.
The U.S. market is fairly consolidated in nature with top four players accounting for over 75% share. Intense competition exists amongst players to offer innovative products at competitive prices. Companies largely rely on strategies like new product launches, geographic expansion and mergers & acquisitions for market penetration. Regulatory approvals and clinical outcomes will remain key for long term success.
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it